Similar articles

• Biomarkers for the early diagnosis of Alzheimer's disease.

  de Leon MJ, Klunk W. de Leon MJ, et al. Lancet Neurol. 2006 Mar;5(3):198-9. doi: 10.1016/S1474-4422(06)70357-X. Lancet Neurol. 2006. PMID: 16488371 No abstract available.
• Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairment.

  Dean RA, Shaw LM. Dean RA, et al. Clin Chem. 2010 Jan;56(1):7-9. doi: 10.1373/clinchem.2009.134692. Epub 2009 Nov 19. Clin Chem. 2010. PMID: 19926774 No abstract available.
• Biomarkers for Alzheimer's disease. The research advances incrementally, but clinical use is still years away.

  [No authors listed] [No authors listed] Harv Ment Health Lett. 2010 Nov;27(5):1-3. Harv Ment Health Lett. 2010. PMID: 21218612 No abstract available.
• Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.

  Marksteiner J, Hinterhuber H, Humpel C. Marksteiner J, et al. Drugs Today (Barc). 2007 Jun;43(6):423-31. doi: 10.1358/dot.2007.43.6.1067341. Drugs Today (Barc). 2007. PMID: 17612711 Review.
• Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

  Sjögren M, Andreasen N, Blennow K. Sjögren M, et al. Clin Chim Acta. 2003 Jun;332(1-2):1-10. doi: 10.1016/s0009-8981(03)00121-9. Clin Chim Acta. 2003. PMID: 12763273 Review.